A randomized placebo-controlled trial of oral alendronate children and adolescents with osteogenesis imperfecta

被引：0
|
作者：
Ward, LM
Glorieux, FH
Rauch, F
Verbruggen, N
Heyden, N
Lombardi, A
机构：
[1] Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study
    Ward, L. M.
    Rauch, F.
    Whyte, M. P.
    D'Astous, J.
    Gates, P. E.
    Grogan, D.
    Lester, E. L.
    McCall, R. E.
    Pressly, T. A.
    Sanders, J. O.
    Smith, P. A.
    Steiner, R. D.
    Sullivan, E.
    Tyerman, G.
    Smith-Wright, D. L.
    Verbruggen, N.
    Heyden, N.
    Lombardi, A.
    Glorieux, F. H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (02): : 355 - 364
  • [2] Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: A 3-year randomized placebo-controlled trial
    Chevrel, G
    Schott, AM
    Fontanges, E
    Charrin, JE
    Lina-Granade, G
    Duboeuf, F
    Garnero, P
    Arlot, M
    Raynal, C
    Meunier, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (02) : 300 - 306
  • [3] Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial
    Dieke H. J. Kok
    Ralph J. B. Sakkers
    Arieke J. Janse
    Hans E. H. Pruijs
    Ab J. Verbout
    Rene M. Castelein
    Raoul H. H. Engelbert
    European Journal of Pediatrics, 2007, 166 : 1155 - 1161
  • [4] Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial
    Kok, Dieke H. J.
    Sakkers, Ralph J. B.
    Janse, Arieke J.
    Pruijs, Hans E. H.
    Verbout, Ab J.
    Castelein, Rene M.
    Engelbert, Raoul H. H.
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (11) : 1155 - 1161
  • [5] Efficacy of oral alendronate in children with osteogenesis imperfecta
    Cho, TJ
    Choi, IH
    Chung, CY
    Yoo, WJ
    Park, MS
    Park, YK
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2005, 25 (05) : 607 - 612
  • [6] Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial
    Bishop, Nick
    Adami, Silvano
    Ahmed, S. Faisal
    Anton, Jordi
    Arundel, Paul
    Burren, Christine P.
    Devogelaer, Jean-Pierre
    Hangartner, Thomas
    Eva Hosszu
    Lane, Joseph M.
    Lorenc, Roman
    Makitie, Outi
    Munns, Craig F.
    Paredes, Ana
    Pavlov, Helene
    Plotkin, Horacio
    Raggio, Cathleen L.
    Loreto Reyes, Maria
    Schoenau, Eckhard
    Semler, Oliver
    Sillence, David O.
    Steiner, Robert D.
    LANCET, 2013, 382 (9902): : 1424 - 1432
  • [7] Oral alendronate in osteogenesis imperfecta
    Unal, E
    Abaci, A
    Bober, E
    Buyukgebiz, A
    INDIAN PEDIATRICS, 2005, 42 (11) : 1158 - 1160
  • [8] A randomized, controlled study of oral alendronate vs. IV pamidronate therapy for children with osteogenesis imperfecta.
    DiMeglio, LA
    Ford, L
    McClintock, C
    McClintock, R
    Peacock, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S100 - S100
  • [9] Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study
    Rauch, Frank
    Munns, Craig F.
    Land, Christof
    Cheung, Moira
    Glorieux, Francis H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (07) : 1282 - 1289
  • [10] Risedronate in the treatment of mild pediatric osteogenesis imperfecta: A randomized placebo-controlled study
    Cheung, M. S.
    Rauch, F.
    Cornibert, S.
    Munns, C.
    Land, C.
    Glorieux, F.
    BONE, 2007, 40 (06) : S33 - S34
12345